FLT4 and hydrops fetalis: Taken together, these results indicate that VEGF‐C156S‐VEGFR‐3 axis‐dependent lymphangiogenesis is crucially involved in the transition from compensatory hypertrophy to HF and suggest that this pathway may be a promising target for the treatment of this disease.